RT Journal Article
SR Electronic
T1 Imaging Biomarkers in Lung Cancer with <sup>68</sup>Ga-DOTATATE, <sup>18</sup>F-Fluoride, and <sup>18</sup>F-FDG PET/CT Scans and the Theranostics Paradigm
JF Journal of Nuclear Medicine Technology
JO J. Nucl. Med. Technol.
FD Society of Nuclear Medicine
SP 281
OP 283
DO 10.2967/jnmt.120.258343
VO 49
IS 3
A1 Djekidel, Mehdi
A1 Syed, Ghulam
A1 Kanbour, Aladdin
YR 2021
UL http://tech.snmjournals.org/content/49/3/281.abstract
AB Lung cancer is the number 1 cause of cancer deaths in the United States. The prognosis is quite grim with the exception of stage 1. When faced with several failed therapeutic regimens and rapid progression of the disease, considering alternative therapies such as radiopharmaceutical therapies may be an option. We describe the case of a 36-y-old man with lung adenocarcinoma who had imaging molecular characterization of his disease with 18F-FDG, 68Ga-DOTATATE, and 18F-fluoride PET/CT scans that were able to shed some light on molecular characterization of his disease and serve as a guide to potential targeted or personalized radiopharmaceutical therapeutic options.